OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
OncoSwab has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
OncoSwab's investors include Innosuisse, Health Wildcatters, DayOne accelerator.
OncoSwab is headquartered in San Francisco, United States.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
OncoSwab is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoSwab — Funding & Investors." VCBacked, May 2, 2025, https://www.vcbacked.co/company/oncoswab. Accessed September 14, 2026.
VCBacked. (2025). OncoSwab — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/oncoswab
{{cite web |title=OncoSwab — Funding & Investors |url=https://www.vcbacked.co/company/oncoswab |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated